Background: Women with severe Hypertrophic Cardiomyopathy (HCM) can successfully undergo pregnancy without significant maternal or fetal complications. The optimal management strategies however still remain fairly unknown.
OUTCOME OF CARDIAC THROMBI IN INFANTS.
E A Bendaly, A S Batra, E S Ebenroth, R A Hurwitz, Riley Hospital for Children, Indiana University School Of Medicine, Indianapolis, IN.
Cardiac masses in neonates are extremely rare and usually represent either tumors or thrombi. Management of cardiac tumors has been well described in this patient population, but a paucity of data exists on the management of cardiac thrombi, with the few reported cases focusing on outcomes following thrombolytic therapy (rt-PA, urokinase, or streptokinase). This study was undertaken to evaluate the outcome of cardiac thrombi in neonates who do not receive thrombolytic therapy.
Our echocardiographic database from November 1999 to November 2004 revealed 19 patients younger than 3 months of age [mean age ϭ 41 Ϯ 27 days (range 6 to 99 days)] when diagnosed with cardiac thrombi.
All 19 patients had a central venous line at the time of diagnosis. The median duration of central line prior to thrombus identification was 11 days (range 2 to 51 days). Sixteen (84%) had a thrombus attached to the endocardium [right atrium (nϭ11), right ventricle (nϭ2), left atrium (nϭ3)] and three (16%) had thrombi attached to the end of a central venous line within the right atrium. Nine patients (47%) had negative blood cultures, and complete resolution of the thrombus occurred in all of them within 24 Ϯ 24 days (range 0 day to 77 days). These patients were treated with LMWH or heparin (nϭ2), antibiotics (nϭ2), both (nϭ2), surgical removal of the thrombus (nϭ2), or no therapy (nϭ1). In the 10 patients with positive blood cultures (53%), complete resolution occurred in 9 cases (90%) after a mean of 70 Ϯ 58 days (range 5 to 166 days). Treatment consisted of either antimicrobials alone (nϭ5), or combination of LMWH or coumadin and antimicrobials (nϭ4). One patient doing well was lost to follow-up after 72 days. No patient had evidence of thrombus embolization.
The natural history of cardiac thrombi is that they resolve over time. Infected thrombi may require more prolonged therapy. Surgery is seldom required and thrombolytics are not usually necessary. To determine if post-mortem family conferences would have a positive impact on the healing process of families who experience the loss of their newborn. Through a questionnaire, we evaluated our experience and effectiveness in dealing with multiple aspects of the family's loss. We further evaluated our experience with the loss of a newborn to formulate a model in bereavement.
DEALING WITH BEREAVEMENT IN THE NEONATAL INTENSIVE CARE UNIT (NICU
METHODS: We identified 370 newborns that expired in our NICU over an 11 year period (1994 -2005) . Under IRB approval, we sent a questionnaire to evaluate the family's emotional, social and vocational adaptation after the loss. Of the 370 families identified, 104 were excluded due to no forwarding address and/or incomplete database. Of the remaining 266 families, 29 (11%) responded.
RESULTS (N ϭ 29)
CONCLUSIONS: Based on our data, a specific bereavement team should be identified to implement a consistent approach and follow up for families that experience the loss of a newborn. A post mortem conference appears to reduce the intensity of the grieving process and provide comprehensive support. Offering this conference should be mandatory. Autopsy consent and obstetrical involvement can be improved. This approach can provide experience and education in this humanistic side of medicine relevant to all members of the healthcare team who care for critically ill newborns.
REDUCED NEONATAL CANDIDA INFECTION AS A RESULT OF MEDICAL PRACTICE INTERVENTION
Maliha J Shareef , Kamlesh S. Macwan, James R. Hocker, Susan E. Clark, Susan B Ramiro, Vi Albert, Sharon Klein. Dept. of Pediatrics, St. Francis Medical Center, Peoria, Illinois, United States Objective: To assess the impact of a medical practice intervention on the incidence of Candida spp. sepsis among neonates with a birth weight of Յ 750 grams admitted to a level 3 neonatal intensive care unit (NICU).
Methods: In July 1996 implementation of medical practice included;(1) administration of oral nystatin (every 6 hours for the first week of life and with each antibiotic course during the first four weeks of life). (2) Modifying parameters for extubation, (3) Early discontinuation of central lines (UAC, UVC, PCVC, CL), (4) Parenteral nutrition (PN) and antibiotics. We reviewed charts and collected data from January 1, 1995 to December 31, 1998. Neonates who died at Յ 3days of age or were admitted at Ն 7days of age were excluded. The intervention group consisted of 69 neonates, admitted between July 1, 1996 and December 31, 1998 and the control group consisted of 45 neonates, admitted between January 1, 1995 and June 30, 1996. We measured the outcome by using student t test and standard logistic regression techniques. The above management plan was continued after the study period. Retrospective analysis of the incidence of Candida infection in NICU was followed for 1999 to 2004.
Results: The intervention group experienced fewer episodes of Candida spp. sepsis, OR 0.07 (pϭϽ0.0002) adjusting for gestational age, mode of delivery and number of days of central vascular access. The estimated gestational age was longer (EGA) (24.9 vs. 24.4 pϭϽ0.05) and more neonates received feedings (93% vs. 73%, pϭϽ0.05). Within the intervention group, exposure to high humidity environment was associated with a higher risk of Candida spp. sepsis, OR 10.5 (pϽ0.06). The incidence of candida spp. During 1999 to 2004 remained between 0% to 3%.
Conclusion: Oral nystatin administration substantially reduced the risk of Candida spp. sepsis among neonates with birth weight Յ 750g, while vaginal delivery was an independent risk factor. High humidity environment may be an additional risk factor for developing Candida spp. sepsis.
ADVERSE EVENTS IN PEDIATRIC KETAMINE SEDATIONS WITH AND WITHOUT MORPHINE PRETREATMENT
Waterman GD, Leder MS, Cohen DM; City/State: Columbus, Ohio; Institution: Children's Hospital, Columbus, Ohio, Emergency Medicine, Department of Pediatrics, The Ohio State University Purpose: To assess outcomes between two groups of patients receiving ketamine for procedural sedations in our pediatric emergency department. Our hypothesis is that there is no difference in the number of adverse events in ketamine sedations with and without morphine pretreatment.
Method: This was a retrospective cohort study of all ketamine sedation records over 15 months. The number and types of adverse events between patients with and without morphine pretreatment were compared, using a z-score and p-values were obtained. The possible influence of midazolam coadministration was examined, using Fisher's exact and Pearson chi-square tests.
Results: 858 sedations were reviewed. Age, weight, and medication dosages were similar in each group. 21 adverse events were recorded in the group of patients with no morphine pretreatment; and, 13 adverse events in the group with morphine pretreatment. No significant differences were found for the number or types of events. There was no difference for the frequency of midazolam co-administration, Pearson chi-square, p ϭ 0.994; nor for the number of adverse events in each group, Fisher's exact test, p ϭ 0.465. The mean time from morphine administration to procedural sedation was 114.7 minutes. One adverse event occurred in the 15 min or less time interval.
Conclusions: We found no increased adverse events with morphine pretreatment in ketamine sedations for children. Prospective studies to validate these findings, including an effect of timing of analgesia administration are warranted.
EARLY RECURRENCE OF CRESENTRIC GLOMERULONEPHRITIS AF-TER PEDIATRIC RENAL TRANSPLANTATION:
S Jain, E John, S Setty, E Benedetti, University of Illinois at Chicago Medical Center, Chicago, IL Introduction: Recurrence of primary disease such as focal segmental glomerulosclerosis or hemolytic uremic syndrome may cause early graft dysfunction after pediatric kidney transplantation. We report the unusual occurrence of early graft dysfunction following kidney transplant in two pediatric cases due to biopsy proven recurrence of cresentric glomerulonephritis (CGN) which is very rare.
Methods: Of the 75 renal transplants performed in patients aged Ͻ18 years at our center from 1996 -2004, 2 patients had an early recurrence of CGN (in less than 7 days) leading to acute graft dysfunction. In order to rule out the different etiologies which could present as CGN in the biopsy, tests for anti-glomerular basement membrane antibodies (anti-GBM), anti-nuclear antibodies (ANA), anti-neutrophil cytoplasmic antibodies (ANCA, p-perinuclear staining, c-cytoplasmic granular staining), serum complement C3, C4 levels and immunofluorescent (IF) tests were done.
Results: Patient A was able to recover her renal function following aggressive treatment with plasmapheresis, intravenous (IV) cyclophosphamide and methylprednisolone. Twelve years after the transplant, her serum creatinine continues to be near normal (1.5 mg/dl). In patient B, plasmapheresis before and after the transplantation along with IV cyclophosphamide and methylprednisolone did not prevent graft failure, who is currently on chronic peritoneal dialysis.
Conclusion: Early recurrence of CGN though uncommon, should be considered in the differential diagnoses of early graft dysfunction after renal transplantation in children. Early diagnosis and treatment in some patients with CGN can lead to recovery of graft function thus improving the positive outcome after transplantation.
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